Skip to main navigation
  • Our Product
  • Investors

    Investor Relations

    • Investor Relations
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Investor Resources
Fennec Pharmaceuticals
  • Our Product
  • Investors
    • Investor Relations
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Investor Resources

    Investor Relations

    • Investor Relations
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Investor Resources

You are here: Home / Investors

    FENNEC TO PRESENT AT PIONEERS 2017 JOSEPH GUNNAR CONFERENCE ON MAY 2, 2017 IN NEW YORK CITY

    • Read more about FENNEC TO PRESENT AT PIONEERS 2017 JOSEPH GUNNAR CONFERENCE ON MAY 2, 2017 IN NEW YORK CITY

    FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES FIRST QUARTER 2017 RESULTS

    • Read more about FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES FIRST QUARTER 2017 RESULTS

    FENNEC ANNOUNCES LAUNCH OF EUROPEAN NAMED PATIENT PROGRAMME FOR SODIUM THIOSULFATE FOR PEDIATRIC PATIENTS WITH STANDARD RISK HEPATOBLASTOMA

    • Read more about FENNEC ANNOUNCES LAUNCH OF EUROPEAN NAMED PATIENT PROGRAMME FOR SODIUM THIOSULFATE FOR PEDIATRIC PATIENTS WITH STANDARD RISK HEPATOBLASTOMA

    FENNEC ANNOUNCES $7.6 MILLION PRIVATE PLACEMENT OF COMMON SHARES LED BY VENBIO SELECT ADVISOR

    • Read more about FENNEC ANNOUNCES $7.6 MILLION PRIVATE PLACEMENT OF COMMON SHARES LED BY VENBIO SELECT ADVISOR

    FENNEC ANNOUNCES RESULTS OF ANNUAL MEETING

    • Read more about FENNEC ANNOUNCES RESULTS OF ANNUAL MEETING

    FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES SECOND QUARTER 2017 RESULTS

    • Read more about FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES SECOND QUARTER 2017 RESULTS

    FENNEC PHARMACEUTICALS ANNOUNCES LISTING ON THE NASDAQ CAPITAL MARKET

    • Read more about FENNEC PHARMACEUTICALS ANNOUNCES LISTING ON THE NASDAQ CAPITAL MARKET

    FENNEC ANNOUNCES PRELIMINARY RESULTS OF SIOPEL 6 STUDY ON PEDMARK™ (SODIUM THIOSULFATE) TO BE PRESENTED AT THE 49TH CONGRESS OF THE INTERNATIONAL SOCIETY OF PEDIATRIC ONCOLOGY (SIOP) 2017 MEETING

    • Read more about FENNEC ANNOUNCES PRELIMINARY RESULTS OF SIOPEL 6 STUDY ON PEDMARK™ (SODIUM THIOSULFATE) TO BE PRESENTED AT THE 49TH CONGRESS OF THE INTERNATIONAL SOCIETY OF PEDIATRIC ONCOLOGY (SIOP) 2017 MEETING

    FENNEC TO PRESENT AT THE CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE ON SEPTEMBER 27, 2017 IN NEW YORK CITY

    • Read more about FENNEC TO PRESENT AT THE CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE ON SEPTEMBER 27, 2017 IN NEW YORK CITY

    Pagination

    • First page « First
    • Previous page ‹ Previous
    • …
    • Page 9
    • Page 10
    • Page 11
    • Page 12
    • Page 13
    • Page 14
    • Page 15
    • Page 16
    • Current page 17
    Subscribe to

    Investor Tools

    • Print Page
    • Email Alerts
    • Contact IR
    • RSS Feeds

    Investor Relations

    • Investor Relations
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Investor Resources
    Copyright © 2025 Fennec Pharmaceuticals
    Scroll to top